INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 342 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $555,532 | +53.4% | 17,569 | +69.2% | 0.10% | +105.9% |
| Q4 2022 | $362,263 | -46.0% | 10,383 | +12.5% | 0.05% | -56.0% |
| Q1 2022 | $671,000 | +64.1% | 9,233 | +81.3% | 0.12% | +114.8% |
| Q1 2021 | $409,000 | -18.4% | 5,093 | -44.7% | 0.05% | -16.9% |
| Q4 2020 | $501,000 | -73.4% | 9,212 | -89.7% | 0.06% | -73.1% |
| Q2 2020 | $1,883,000 | +301.5% | 89,571 | +133.6% | 0.24% | +290.3% |
| Q1 2020 | $469,000 | – | 38,350 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |